Optimization of TNF-α overexpression in Escherichia coli using response surface methodology: Purification of the protein and oligomerization studies.

Tumor necrosis factor-α (TNF-α) is responsible for many autoimmune disorders including rheumatoid arthritis, psoriasis, Chron's disease, stroke, and atherosclerosis. Thus, inhibition of TNF-α is a major challenge in drug discovery. However, a sufficient amount of purified protein is needed for the in vitro screening of potential TNF-α inhibitors. In this work, induction conditions for the production of human TNF-α fusion protein in a soluble form by recombinant Escherichia coli BL21(DE3) pLysS were optimized using response surface methodology based on the central composite design. The induction conditions included cell density prior induction (OD(600nm)), post-induction temperature, IPTG concentration and post-induction time. Statistical analysis of the results revealed that all variables and their interactions had significant impact on production of soluble TNF-α. An 11% increase of TNF-α production was achieved after determination of the optimum induction conditions: OD(600nm) prior induction 0.55, a post induction temperature of 25°C, an IPTG concentration of 1mM and a post-induction time of 4h. We have also studied TNF-α oligomerization, the major property of this protein, and a K(d) value of 0.26nM for protein dimerization was determined. The concentration of where protein trimerization occurred was also detected. However, we failed to determine a reliable K(d) value for protein trimerization probably due to the complexibility of our model.

[1]  N. Nancib,et al.  Variation and modeling of the probability of plasmid loss as a function of growth rate of plasmid‐bearing cells of Escherichia coli during continuous cultures , 1993, Biotechnology and bioengineering.

[2]  A. Whitty,et al.  Small-molecule inhibition of TNF-alpha. , 2005, Science.

[3]  George Kollias,et al.  A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF. , 2012, Human molecular genetics.

[4]  A. Corti,et al.  Mechanism of suramin-induced deoligomerization of tumor necrosis factor alpha. , 1995, Biochemistry.

[5]  H. P. Sørensen,et al.  Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli , 2005 .

[6]  F. Baneyx,et al.  Expression of aggregation-prone recombinant proteins at low temperatures: a comparative study of the Escherichia coli cspA and tac promoter systems. , 1997, Protein expression and purification.

[7]  M. Feldmann,et al.  Development of anti-TNF therapy for rheumatoid arthritis , 2002, Nature Reviews Immunology.

[8]  J. Thornton,et al.  Structural characterisation and functional significance of transient protein-protein interactions. , 2003, Journal of molecular biology.

[9]  G. Petersen,et al.  Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins. , 2006, Protein expression and purification.

[10]  B. Aggarwal Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.

[11]  J. Koehn,et al.  High-Throughput Protein Production (HTPP): a review of enabling technologies to expedite protein production. , 2009, Methods in molecular biology.

[12]  Jun Wang,et al.  Small-Molecule Inhibition of TNF-α , 2005, Science.

[13]  R. Rudolph,et al.  In vitro folding of inclusion body proteins , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  D. MacEwan TNF receptor subtype signalling: differences and cellular consequences. , 2002, Cellular signalling.

[15]  P. Loppnau,et al.  A screening strategy for heterologous protein expression in Escherichia coli with the highest return of investment. , 2012, Protein expression and purification.

[16]  Barbara Imperiali,et al.  Protein Oligomerization: How and Why , 2005 .

[17]  Jung-Eun Park,et al.  Structure based optimization of chromen-based TNF-α converting enzyme (TACE) inhibitors on S1' pocket and their quantitative structure-activity relationship (QSAR) study. , 2010, Bioorganic & medicinal chemistry.

[18]  Yan Feng,et al.  Optimization of recombinant hyperthermophilic esterase production from agricultural waste using response surface methodology. , 2006, Bioresource technology.

[19]  W D Luzier,et al.  Materials derived from biomass/biodegradable materials. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[21]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[22]  F. Baneyx Recombinant protein expression in Escherichia coli. , 1999, Current opinion in biotechnology.

[23]  V. Sahai,et al.  Enhanced expression of the recombinant lethal factor of Bacillus anthracis by Fed-Batch culture. , 2001, Biochemical and biophysical research communications.

[24]  C. Nelson,et al.  Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity. , 2001, The Journal of clinical investigation.

[25]  M. Khodabandeh,et al.  Response surface methodology for optimizing the induction conditions of recombinant interferon beta during high cell density culture , 2008 .

[26]  A. Corti,et al.  Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels. , 1992, The Biochemical journal.

[27]  A. Xu,et al.  Production of a new sea anemone neurotoxin by recombinant Escherichia coli: Optimization of culture conditions using response surface methodology , 2005 .

[28]  Margaret J. Robertson,et al.  Design and Analysis of Experiments , 2006, Handbook of statistics.

[29]  P. Szlosarek,et al.  Tumour necrosis factor-α as a tumour promoter , 2006 .

[30]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[31]  P. Szlosarek,et al.  Tumour necrosis factor-alpha as a tumour promoter. , 2006, European journal of cancer.

[32]  M. Kharrati-Kopaei,et al.  Optimization of an extracellular zinc-metalloprotease (SVP2) expression in Escherichia coli BL21 (DE3) using response surface methodology. , 2012, Protein expression and purification.

[33]  A. Corti,et al.  Oligomeric tumour necrosis factor α slowly converts into inactive forms at bioactive levels , 1992 .

[34]  Hao Sun,et al.  Metabolic activation of a novel 3-substituted indole-containing TNF-alpha inhibitor: dehydrogenation and inactivation of CYP3A4. , 2008, Chemical research in toxicology.

[35]  S. Singh,et al.  Solubilization and refolding of bacterial inclusion body proteins. , 2005, Journal of bioscience and bioengineering.

[36]  A. L. Larentis,et al.  Cloning and optimization of induction conditions for mature PsaA (pneumococcal surface adhesin A) expression in Escherichia coli and recombinant protein stability during long-term storage. , 2011, Protein expression and purification.

[37]  A. Poustka,et al.  Large‐scale protein expression for proteome research , 2005, Proteomics.

[38]  Douglas C. Montgomery,et al.  Response Surface Methodology: Process and Product Optimization Using Designed Experiments , 1995 .

[39]  A. Xu,et al.  Functional expression and characterization of a recombinant phospholipase A2 from sea snake Lapemis hardwickii as a soluble protein in E. coli. , 2003, Toxicon : official journal of the International Society on Toxinology.

[40]  D. Kioussis,et al.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. , 1991, The EMBO journal.